TAKEDA GMBH et al v. MYLAN PHARMACEUTICALS INC.
| TAKEDA GMBH, ASTRAZENECA PHARMACEUTICALS LP and ASTRAZENECA UK LIMITED |
| MYLAN PHARMACEUTICALS INC. |
| 3:2015cv03384 |
| May 15, 2015 |
| US District Court for the District of New Jersey |
| Trenton Office |
| Mercer |
| Douglas E. Arpert |
| Freda L. Wolfson |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
40
MEMORANDUM OPINION AND ORDER administratively terminating 12 Motion to Dismiss; that this matter will be STAYED pending the outcome of AstraZeneca AB, Civ. No 15-1460; that any party to this litigation may move to lift this stay if their rights in this matter are substantively effected by the pendency of the Federal Circuits decision. Signed by Judge Freda L. Wolfson on 1/12/2016. (mmh)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
